TTK Healthcare Limited (TTKHLTCARE.NS)
INR 1211.1
(-2.27%)
INR 1211.1
(-2.27%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 44.47 INR | -90.18% |
| 2022 | 452.73 INR | 1438.33% |
| 2021 | 29.43 INR | -10.47% |
| 2020 | 32.87 INR | 276.95% |
| 2019 | 8.72 INR | -49.45% |
| 2018 | 17.25 INR | 34.14% |
| 2017 | 12.86 INR | -46.71% |
| 2016 | 24.13 INR | -17.33% |
| 2015 | 29.19 INR | 40.34% |
| 2014 | 20.80 INR | 30.41% |
| 2013 | 15.95 INR | -12.79% |
| 2012 | 18.29 INR | -9.14% |
| 2011 | 20.13 INR | 6.17% |
| 2010 | 18.96 INR | 62.33% |
| 2009 | 11.68 INR | 20.29% |
| 2008 | 9.71 INR | -35.4% |
| 2007 | 15.03 INR | 275.75% |
| 2006 | 4.00 INR | 32.01% |
| 2005 | 3.03 INR | 306.12% |
| 2004 | -1.47 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 22.35 INR | 72.85% |
| 2024 Q2 | 12.17 INR | -45.55% |
| 2023 Q4 | 12.93 INR | 41.62% |
| 2023 Q3 | 9.13 INR | -19.42% |
| 2023 FY | - INR | -90.18% |
| 2023 Q1 | 11.09 INR | -7.51% |
| 2023 Q2 | 11.33 INR | 2.16% |
| 2022 Q2 | 7.02 INR | -98.35% |
| 2022 Q4 | 11.99 INR | 41.22% |
| 2022 FY | - INR | 1438.33% |
| 2022 Q1 | 425.23 INR | 5554.65% |
| 2022 Q3 | 8.49 INR | 20.94% |
| 2021 Q2 | 9.06 INR | 113.68% |
| 2021 Q1 | 4.24 INR | -42.08% |
| 2021 Q3 | 8.61 INR | -4.97% |
| 2021 FY | - INR | -10.47% |
| 2021 Q4 | 7.52 INR | -12.66% |
| 2020 Q4 | 7.32 INR | 34.56% |
| 2020 Q2 | 21.80 INR | 1382.35% |
| 2020 FY | - INR | 276.95% |
| 2020 Q1 | -1.70 INR | -666.67% |
| 2020 Q3 | 5.44 INR | -75.05% |
| 2019 Q3 | 3.17 INR | 18.28% |
| 2019 FY | - INR | -49.45% |
| 2019 Q4 | 0.30 INR | -90.54% |
| 2019 Q2 | 2.68 INR | 3.88% |
| 2019 Q1 | 2.58 INR | -26.5% |
| 2018 Q4 | 3.51 INR | 1.45% |
| 2018 FY | - INR | 34.14% |
| 2018 Q3 | 3.46 INR | -26.54% |
| 2018 Q2 | 4.71 INR | -15.59% |
| 2018 Q1 | 5.58 INR | -1.41% |
| 2017 Q3 | 15.77 INR | 98.87% |
| 2017 Q4 | 5.66 INR | -64.11% |
| 2017 FY | - INR | -46.71% |
| 2017 Q1 | -3.17 INR | -149.0% |
| 2017 Q2 | 7.93 INR | 350.16% |
| 2016 Q3 | 4.60 INR | -21.5% |
| 2016 Q4 | 6.47 INR | 40.65% |
| 2016 Q1 | 7.20 INR | 71.02% |
| 2016 Q2 | 5.86 INR | -18.61% |
| 2016 FY | - INR | -17.33% |
| 2015 Q2 | 6.08 INR | 0.16% |
| 2015 Q4 | 4.21 INR | -55.17% |
| 2015 FY | - INR | 40.34% |
| 2015 Q1 | 6.07 INR | 87.93% |
| 2015 Q3 | 9.39 INR | 54.44% |
| 2014 Q1 | 4.66 INR | 102.61% |
| 2014 FY | - INR | 30.41% |
| 2014 Q4 | 3.23 INR | -40.19% |
| 2014 Q3 | 5.40 INR | 10.88% |
| 2014 Q2 | 4.87 INR | 4.51% |
| 2013 Q4 | 2.30 INR | -48.89% |
| 2013 FY | - INR | -12.79% |
| 2013 Q3 | 4.50 INR | -3.43% |
| 2013 Q2 | 4.66 INR | 78.54% |
| 2013 Q1 | 2.61 INR | 64.15% |
| 2012 FY | - INR | -9.14% |
| 2012 Q2 | 5.20 INR | -16.8% |
| 2012 Q1 | 6.25 INR | 137.64% |
| 2012 Q4 | 1.59 INR | -59.64% |
| 2012 Q3 | 3.94 INR | -24.23% |
| 2011 Q4 | 2.63 INR | -50.38% |
| 2011 Q3 | 5.30 INR | 0.0% |
| 2011 FY | - INR | 6.17% |
| 2010 FY | - INR | 62.33% |
| 2009 FY | - INR | 20.29% |
| 2008 FY | - INR | -35.4% |
| 2007 FY | - INR | 275.75% |
| 2006 FY | - INR | 32.01% |
| 2005 FY | - INR | 306.12% |
| 2004 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Abbott India Limited | 565.30 INR | 92.133% |
| Cipla Limited | 51.05 INR | 12.889% |
| Gland Pharma Limited | 46.90 INR | 5.181% |
| GlaxoSmithKline Pharmaceuticals Limited | 34.83 INR | -27.677% |
| Kopran Limited | 10.57 INR | -320.719% |
| Marksans Pharma Limited | 6.92 INR | -542.63% |
| NGL Fine-Chem Limited | 66.88 INR | 33.508% |
| Pfizer Limited | 120.51 INR | 63.098% |
| Sanofi India Limited | 261.78 INR | 83.012% |
| SMS Pharmaceuticals Limited | 5.89 INR | -655.008% |